Abstract
The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was investigated in a population that approximates sexually naive women in that they were "negative to 14 HPV types" and in a mixed population of HPV-exposed and -unexposed women (intention-to-treat group).
| Original language | English |
|---|---|
| Journal | National Cancer Institute. Journal (Online) |
| Volume | 102 |
| Issue number | 5 |
| Pages (from-to) | 325-39 |
| Number of pages | 15 |
| ISSN | 1460-2105 |
| DOIs | |
| Publication status | Published - 3 Mar 2010 |